Plus Therapeutics (PSTV) was granted FDA orphan designation for a treatment of lung cancer with leptomeningeal metastases, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
